Insights

Gathering insights about IMD…

Similar companies to IMD

IMD Tech Stack

IMD uses 8 technology products and services including Power BI, Tableau, MySQL, and more. Explore IMD's tech stack below.

Power BI
Business Intelligence
Tableau
Business Intelligence
MySQL
Database
Cart Functionality
E-commerce
AngularJS
Javascript Frameworks
JSON-LD
Javascript Frameworks
iOS
Programming Languages
Python
Programming Languages

Media & News

Insight Molecular Diagnostics Inc. (IMDX) Q3 2025 Earnings Call Transcript
Insight Molecular Diagnostics Inc. ( IMDX ) Q3 2025 Earnings Call November 10, 2025 5:00 PM EST Company Participants Gabrielle Woody - Sr. Executive Assistant Joshua Riggs - President, CEO & Director Andrea James - Chief Financial Officer Ekkehard Schutz - Chief Science Officer Conference Call Participants Mark Massaro - BTIG, LLC, Research Division Harrison Parsons - Stephens Inc., Research Division Michael Matson - Needham & Company, LLC, Research Division Thomas Flaten - Lake Street Capital Markets, LLC, Research Division Presentation Gabrielle Woody Sr. Executive Assistant Greetings, everyone, and welcome, everyone, and thank you for joining us to discuss Insight Molecular Diagnostics Third Quarter 2025 Results. If you have not seen today's shareholder letter, please visit Insight Molecular Diagnostics Investor Relations page at investors.imdxinc.com.
Nov 11, 2025 | seekingalpha.com
IMDX Reports Q3 2025 Results and Progress Toward 2026 Commercial Launch
On track to submit GraftAssureDx™ for FDA review by year-end On track for commitment to have 20 transplant centers globally engaged with GraftAssure technology by end of 2025 GraftAssure assay's head-to-head data continue to be favorable Preparing to rapidly expand beyond kidney into heart transplant testing NASHVILLE, Tenn., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., or iMDx, (Nasdaq: IMDX), today published the following letter to shareholders in conjunction with its third quarter results: Fellow shareholders, There is a palpable level of excitement and activation energy coursing through our company as we prepare to submit our application for approval of our first molecular diagnostic test kit for clinical use, GraftAssureDx™, to the FDA.
Nov 10, 2025 | www.globenewswire.com
iMDx to Release Third Quarter 2025 Results on November 10 and Attend Stephens Annual Investment Conference the Following Week
NASHVILLE, Tenn., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will report third quarter 2025 financial results after the market closes on Monday, November 10, 2025.
Nov 03, 2025 | www.globenewswire.com
iMDx Welcomes New VP Marketing to Prepare for Commercial Transplant Assay Launch
NASHVILLE, Tenn., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it has welcomed Steven Tahmooressi to its executive leadership team as the company prepares to launch its first clinical kitted assay in 2026.
Oct 13, 2025 | www.globenewswire.com
iMDx Reports Kidney Transplant Patient Achieved ‘Immune Reset' with Novel Therapy and GraftAssure Monitoring
NASHVILLE, Tenn., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced results from a study conducted by iMDx researchers and partners published in the American Journal of Transplantation, that demonstrated the value of its GraftAssure assay for long-term monitoring of a kidney transplant patient with severe complications requiring novel therapy.
Oct 06, 2025 | www.globenewswire.com
Insight Molecular Diagnostics to Showcase Leadership in Kidney Transplant Management at Conferences in Singapore and Orlando
NASHVILLE, Tenn., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced attendance at two key industry conferences where it will discuss its GraftAssure™ technology, including its clinical kitted test under development.
Sep 24, 2025 | www.globenewswire.com
Insight Molecular Diagnostics Announces Positive Strategic Update and Novel Registry Database
NASHVILLE, Tenn., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics, Inc. (Nasdaq: IMDX), (“iMDx”), today announced a positive strategic update and novel registry that will serve to gather real-world data on patient experiences and outcomes regarding its flagship kidney transplant rejection assay.
Sep 08, 2025 | www.globenewswire.com

IMD's Email Address Formats

IMD uses at least 1 format(s):

IMD Email Formats	Example	Percentage
First.Last@imd.org	John.Doe@imd.org	88%
Last.First@imd.org	Doe.John@imd.org	5%
Last_First@imd.org	Doe_John@imd.org	4%
First-L@imd.org	John-D@imd.org	3%

Frequently Asked Questions

What is IMD's phone number?

You can contact IMD's main corporate office by phone at

+1-301-797-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is IMD's stock symbol?

IMD is a publicly traded company; the company's stock symbol is IMDX.

What is IMD's official website and social media links?

IMD's official website is imd.org and has social profiles on LinkedIn.

How much revenue does IMD generate?

As of December 2025, IMD's annual revenue is estimated to be $500K.

What is IMD's NAICS code?

IMD's NAICS code is 92311 - Administration of Education Programs.

How many employees does IMD have currently?

As of December 2025, IMD has approximately 2.2K employees across 6 continents, including EuropeAsiaNorth America. Key team members include Chief Executive Officer: V. F.Chief Financial Officer At Imd And Member Of The Executive Committee: P. L. R.Chief Innovation Officer: S. T.. Explore IMD's employee directory with LeadIQ.

What industry does IMD belong to?

IMD operates in the Education Administration Programs industry.

What technology does IMD use?

IMD's tech stack includes Power BITableauMySQLCart FunctionalityAngularJSJSON-LDiOSPython.

What is IMD's email format?

IMD's email format typically follows the pattern of First.Last@imd.org. Find more IMD email formats with LeadIQ.

IMD

Q: What is IMD's official website and social media links?

IMD's official website is imd.org. IMD has social profiles on LinkedIn.

Q: How many employees does IMD have currently?

IMD has approximately 2.2K employees.

Q: What technology does IMD use?

IMD's tech stack includes Juniper Networks, Microsoft, Adobe Fonts, Angular, Sprinklr.

Education Administration ProgramsVaud, Switzerland1001-5000 Employees

At IMD, we develop leaders who transform organizations and contribute to society. We are an independent academic institute with Swiss roots and global reach, established by business leaders for business leaders.